Myeloma Made Simple: Drug Classes Made Simple. Join Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, as he simplifies the complexities of drug classes for myeloma patients. Learn about the mechanisms, benefits, and risks of alkylators, proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and more. Stay informed and empower yourself! Watch now on the International Myeloma Foundation's KZfaq channel. Like, subscribe, and hit the notification bell for future episodes.
The Myeloma Made Simple Series is supported by Janssen Oncology.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-...
Support the IMF | Donate Now! secure.myeloma.org/page/40697...
Category
Nonprofits & Activism
License
Standard KZfaq License
In most cases, captions are autogenerated by KZfaq.